Search

Your search keyword '"RENAL cancer"' showing total 1,631 results

Search Constraints

Start Over You searched for: Descriptor "RENAL cancer" Remove constraint Descriptor: "RENAL cancer" Topic kidney cancer Remove constraint Topic: kidney cancer
1,631 results on '"RENAL cancer"'

Search Results

1. Impact of tumor dissecting technique on trifecta achievement in patients requiring extended warm ischemia during robot-assisted partial nephrectomy.

2. Stereotactic Body Radiotherapy for Renal Cell Carcinoma—A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings.

3. Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis.

4. Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review.

5. Classification and grade prediction of kidney cancer histological images using deep learning.

6. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021.

7. Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysis.

8. Oncological Outcomes of Chromophobe Versus Clear Cell Renal Cell Carcinoma: Results from A Contemporary Turkish Patient Cohort.

9. MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics.

10. Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial.

11. Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial.

12. Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.

13. Multidisciplinary cancer disease classification using adaptive FL in healthcare industry 5.0.

14. Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis.

15. Visual extended reality tools in image-guided surgery in urology: a systematic review.

16. Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.

17. Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer.

18. The Detrimental Effect of Metabolic Syndrome on Long-term Renal Function in Patients Undergoing Elective Partial Nephrectomy for Small Renal Masses

19. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma– results from a nation-wide study covering 50 years in Iceland

20. Increased risk of cardiovascular disease among kidney cancer survivors: a nationwide population-based cohort study.

21. Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials.

22. Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma.

23. Expression of hsa-miRNA-15b, -99b, -181a and Their Relationship to Angiogenesis in Renal Cell Carcinoma.

24. Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond.

25. Kidney Cancer and Potential Use of Urinary Extracellular Vesicles.

26. Blood cell indices and inflammation-related markers with kidney cancer risk: a large-population prospective analysis in UK Biobank.

27. Perioperative systemic treatments in renal cell carcinoma.

28. Enhanced deep learning based decision support system for kidney tumour detection.

29. Cranial Nerve Palsy and Risk of Kidney Cancer: A Nationwide Population-Based Study.

30. Pulmonary lesion after surgery for renal cancer: progression or new primary?

31. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma– results from a nation-wide study covering 50 years in Iceland.

32. Short‐term psychosocial outcomes of adding a non‐contrast abdominal computed tomography (CT) scan to the thoracic CT within lung cancer screening.

33. Factors Associated With Prescription of Systemic Therapy in Real-world Patients With Metastatic Renal Cell Cancer Managed in a Rural Region.

34. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.

35. A decade long insight into patient views on kidney cancer care delivery.

36. 'Living drugs' target CD70 in advanced renal tumors.

37. All-cause, cardiovascular disease and cancer mortality in the population of a large Italian area contaminated by perfluoroalkyl and polyfluoroalkyl substances (1980–2018).

38. Risk of bladder, kidney and prostate cancer from occupational exposure to welding fumes: a systematic review and meta-analysis.

39. Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.

40. Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.

41. Successful Outcome of a Patient with Concomitant Pancreatic and Renal Carcinoma Receiving Secoisolariciresinol Diglucoside Therapy Alone: A Case Report.

42. SGLT2 inhibition and three urological cancers: Up‐to‐date results.

43. Pre-diagnostic prescription patterns in bladder and renal cancer: a longitudinal linked data study.

44. Risk-stratified screening for the early detection of kidney cancer.

45. Ablative or Surgical Treatment for Small Renal Masses (T1a): A Single-Center Comparison of Perioperative Morbidity and Complications.

46. Primary extrarenal papillary type II renal cell carcinoma presenting as a pelvic mass: a case report and review of the literature.

47. Impact of Palliative Care Utilization among Kidney Cancer Patients in US Hospitals: A National-Scale Analysis.

48. Role of Renal Biopsy in the Management of Renal Cancer: Concordance between Ultrasound/CT-Guided Biopsy Results and Definitive Pathology, Adverse Events, and Complication Rate.

49. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.

50. Therapeutic applications of carbon nanomaterials in renal cancer.

Catalog

Books, media, physical & digital resources